Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-11-24 Sale | 2025-11-25 5:00 pm | Cullinan Therapeutics Inc. | CGEM | Michaelson Jennifer Chief Scientific Officer | 4,000 | $12.3 | $49,200 | 138,004 (Direct) | View |
| 2025-10-28 Purchase | 2025-10-30 5:13 pm | Cullinan Therapeutics Inc. | CGEM | Lynx1 Capital Management LP Nichols Weston 10% Owner | 165,667 | $8.4005 | $1,391,686 | 8,963,500 (Indirect) | View |
| 2025-10-14 Purchase | 2025-10-21 7:00 pm | Cullinan Therapeutics Inc. | CGEM | Lynx1 Capital Management LP Nichols Weston 10% Owner | 248,749 | $8.458 | $2,103,912 | 8,797,833 (Indirect) | View |
| 2025-10-08 Purchase | 2025-10-10 6:58 pm | Cullinan Therapeutics Inc. | CGEM | Lynx1 Capital Management LP Nichols Weston 10% Owner | 1,459,641 | $6.7324 | $9,826,941 | 8,549,084 (Indirect) | View |
| 2025-02-25 Sale | 2025-02-27 5:00 pm | Cullinan Therapeutics Inc. | CGEM | Jones Jeffrey Alan Chief Medical Officer | 4,895 | $8.53 | $41,754 | 174,164 (Direct) | View |
| 2025-02-25 Sale | 2025-02-27 5:00 pm | Cullinan Therapeutics Inc. | CGEM | AHMED NADIM President and CEO | 12,529 | $8.53 | $106,872 | 430,621 (Direct) | View |
| 2025-02-25 Sale | 2025-02-27 5:00 pm | Cullinan Therapeutics Inc. | CGEM | Michaelson Jennifer Chief Scientific Officer | 3,756 | $8.53 | $32,039 | 142,004 (Direct) | View |
| 2025-02-25 Sale | 2025-02-27 5:00 pm | Cullinan Therapeutics Inc. | CGEM | SUMER JACQUELYN L Chief Legal Officer | 3,756 | $8.53 | $32,039 | 136,895 (Direct) | View |
| 2025-01-06 Sale | 2025-01-07 5:00 pm | Cullinan Therapeutics Inc. | CGEM | Michaelson Jennifer Chief Scientific Officer | 4,000 | $12.51 | $50,040 | 95,760 (Direct) | View |
| 2024-12-24 Sale | 2024-12-27 6:00 pm | Cullinan Therapeutics Inc. | CGEM | AHMED NADIM President and CEO | 8,400 | $11.87 | $99,708 | 263,150 (Direct) | View |
| 2024-12-18 Sale | 2024-12-20 5:00 pm | Cullinan Therapeutics Inc. | CGEM | Michaelson Jennifer Chief Scientific Officer | 4,693 | $11.41 | $53,547 | 99,760 (Direct) | View |
| 2024-12-18 Sale | 2024-12-20 5:00 pm | Cullinan Therapeutics Inc. | CGEM | Jones Jeffrey Alan Chief Medical Officer | 4,632 | $11.41 | $52,851 | 114,059 (Direct) | View |
| 2024-12-18 Sale | 2024-12-20 5:00 pm | Cullinan Therapeutics Inc. | CGEM | SUMER JACQUELYN L Chief Legal Officer | 3,482 | $11.41 | $39,730 | 90,651 (Direct) | View |
| 2024-12-12 Sale | 2024-12-16 5:00 pm | Cullinan Therapeutics Inc. | CGEM | Michaelson Jennifer Chief Scientific Officer | 3,489 | $12.52 | $43,682 | 104,453 (Direct) | View |
| 2024-11-05 Sale | 2024-11-07 5:30 pm | Cullinan Therapeutics Inc. | CGEM | Michaelson Jennifer Chief Scientific Officer | 8,000 | $15.64 | $125,120 | 107,942 (Direct) | View |
| 2024-09-05 Sale | 2024-09-09 5:30 pm | Cullinan Therapeutics Inc. | CGEM | Michaelson Jennifer Chief Scientific Officer | 8,000 | $18.09 | $144,720 | 115,942 (Direct) | View |
| 2024-07-05 Sale | 2024-07-09 5:30 pm | Cullinan Therapeutics Inc. | CGEM | Michaelson Jennifer Chief Scientific Officer | 8,000 | $16.33 | $130,640 | 123,942 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2025-10-10 6:56 pm | N/A N/A | Cullinan Therapeutics Inc. | CGEM | Lynx1 Capital Management LP Nichols Weston 10% Owner | 0 | $0 | 7,089,443 (Indirect) | View |
| 2025-08-07 Option Award | 2025-08-08 5:30 pm | N/A 2035-08-07 | Cullinan Therapeutics Inc. | CGEM | Doyle Mittie Director | 79,456 | $0 | 79,456 (Direct) | View |
| 2025-08-07 Option Award | 2025-08-08 5:30 pm | N/A 2035-08-07 | Cullinan Therapeutics Inc. | CGEM | Allen Andrew R Director | 79,456 | $0 | 79,456 (Direct) | View |
| 2025-06-12 Option Award | 2025-06-16 4:14 pm | N/A 2035-06-12 | Cullinan Therapeutics Inc. | CGEM | Ryan David P. Director | 38,513 | $0 | 38,513 (Direct) | View |
| 2025-06-12 Option Award | 2025-06-16 4:12 pm | N/A 2035-06-12 | Cullinan Therapeutics Inc. | CGEM | Rosenberg Anthony Director | 38,513 | $0 | 38,513 (Direct) | View |
| 2025-06-12 Option Award | 2025-06-16 4:10 pm | N/A 2035-06-12 | Cullinan Therapeutics Inc. | CGEM | Webster Stephen W Director | 38,513 | $0 | 38,513 (Direct) | View |
| 2025-06-12 Option Award | 2025-06-16 4:09 pm | N/A 2035-06-12 | Cullinan Therapeutics Inc. | CGEM | Meek David D. Director | 38,513 | $0 | 38,513 (Direct) | View |
| 2025-06-12 Option Award | 2025-06-16 4:07 pm | N/A 2035-06-12 | Cullinan Therapeutics Inc. | CGEM | Martin Anne-Marie Director | 38,513 | $0 | 38,513 (Direct) | View |
| 2025-02-19 Option Award | 2025-02-21 6:00 pm | N/A 2035-02-19 | Cullinan Therapeutics Inc. | CGEM | Michaelson Jennifer Chief Scientific Officer | 150,000 | $0 | 245,760 (Direct) | View |
| 2025-02-19 Option Award | 2025-02-21 6:00 pm | N/A 2035-02-19 | Cullinan Therapeutics Inc. | CGEM | Savill Corrine Chief Business Officer | 112,500 | $0 | 315,990 (Direct) | View |
| 2025-02-19 Option Award | 2025-02-21 6:00 pm | N/A 2035-02-19 | Cullinan Therapeutics Inc. | CGEM | SUMER JACQUELYN L Chief Legal Officer | 150,000 | $0 | 240,651 (Direct) | View |
| 2025-02-19 Option Award | 2025-02-21 6:00 pm | N/A 2035-02-19 | Cullinan Therapeutics Inc. | CGEM | AHMED NADIM President and CEO | 540,000 | $0 | 803,150 (Direct) | View |
| 2025-02-19 Option Award | 2025-02-21 6:00 pm | N/A 2035-02-19 | Cullinan Therapeutics Inc. | CGEM | Jones Jeffrey Alan Chief Medical Officer | 195,000 | $0 | 309,059 (Direct) | View |
| 2025-02-19 Option Award | 2025-02-21 6:00 pm | N/A 2035-02-19 | Cullinan Therapeutics Inc. | CGEM | Fenton Mary Kay Chief Financial Officer | 180,000 | $0 | 180,000 (Direct) | View |
| 2024-08-08 Option Award | 2024-08-09 5:00 pm | N/A 2034-08-08 | Cullinan Therapeutics Inc. | CGEM | Thistle Mary Director | 25,743 | $0 | 25,743 (Direct) | View |
| 2024-07-01 Option Award | 2024-07-02 7:30 pm | N/A N/A | Cullinan Therapeutics Inc. | CGEM | Michaelson Jennifer Chief Scientific Officer | 2,360 | $9 | 131,942 (Direct) | View |
| 2024-06-26 Option Award | 2024-06-27 7:00 pm | N/A 2034-06-26 | Cullinan Therapeutics Inc. | CGEM | Webster Stephen W Director | 15,806 | $0 | 15,806 (Direct) | View |
| 2024-06-26 Option Award | 2024-06-27 7:00 pm | N/A 2034-06-26 | Cullinan Therapeutics Inc. | CGEM | Rosenberg Anthony Director | 15,806 | $0 | 15,806 (Direct) | View |
| 2024-06-26 Option Award | 2024-06-27 7:00 pm | N/A 2034-06-26 | Cullinan Therapeutics Inc. | CGEM | Martin Anne-Marie Director | 15,806 | $0 | 15,806 (Direct) | View |
| 2024-06-26 Option Award | 2024-06-27 7:00 pm | N/A 2034-06-26 | Cullinan Therapeutics Inc. | CGEM | Ryan David P. Director | 15,806 | $0 | 15,806 (Direct) | View |